FDA Approves First Human Trials for Elon Musk’s Brain Chip Company Neuralink, by Andreas Wailzer

Musk claims that ‘merging’ with AI will help humans develop the capacity to stay ahead of and protect themselves from it.

By Andreas Wailzer, LifeSiteNews, May 26, 2023

(LifeSiteNews) — Elon Musk’s brain chip company Neuralink announced that the U.S. Food & Drug Administration (FDA) has approved its product for human trials.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” Musk’s company wrote in a tweet.

“Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!” Neuralink added.

Neuralink has been a passion project for Musk since its founding in 2016. The tech mogul has stated in the past that the connection of the human brain to a computer holds promise for a broad range of applications, from restoring disabled patients’ eyesight and motor function to mentally controlling electronic devices. …

Continue reading >>>>